# US 2021/0228877 A1 · System for variably configurable, adaptable electrode arrays and effectuating software

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0228877 A1
- Document ID: US20210228877A1
- Status: Published application
- Kind: A1
- Application number: 17/170,521
- Filed: 2021-02-08
- Published: 2021-07-29
- Earliest claimed: 2012-11-16
- Assignees: StimScience Inc.
- Applicants: StimScience Inc.
- Inventors: Michael P. WEISEND
- Web page: https://patentgrep.com/patent/US20210228877A1

## CPC

- A61N 1/36025: {for treating a mental or cerebral condition}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/245: specially adapted for magnetoencephalographic [MEG] signals
- A61B 5/291: for electroencephalography [EEG]
- A61B 5/369: Electroencephalography [EEG]
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 6/037: {Emission tomography}
- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/0476: {Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)}
- A61B 5/4094: {Diagnosing or monitoring seizure diseases, e.g. epilepsy}
- A61B 5/4812: {Detecting sleep stages or cycles}
- A61N 1/0526: {Head electrodes (A61N1/0551 takes precedence)}
- A61N 1/3603: {Control systems}
- A61N 2/006: {for magnetic stimulation of nerve tissue}
- A61N 2007/0026: {Stimulation of nerve tissue}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Electrical non-invasive brain stimulation (NIBS) delivers weak electrical currents to the brain via electrodes that are affixed to the scalp. NIBS can excite or inhibit the brain in areas that are impacted by that electrical current during and for a short time following stimulation. Electrical NIBS can be used to change brain structure in terms of increasing white matter integrity as measured by diffusion tensor imaging. Together the electrical NIBS can induce changes in brain structure and function. The present methods and devices are adaptable to and configurable for facilitating the enhancement of brain performance, and the treatment of neurological diseases and tissues. The present methods and devices are advantageously designed to utilize modern electrodes deployed with, inter alia, various spatial arrangements, polarities, and current strengths to target brain areas or networks to thereby enhance performance or deliver therapeutic interventions.

## Claims

### Claim 1

A method of treating a subject, comprising:
recording low level brain activity of the subject corresponding to a low performance state;
recording high level brain activity of the subject corresponding to a high performance state;
determining a difference between the low performance state and the high performance state to produce a difference image;
modeling the difference image to determine a corresponding pattern of electrical activity;
identifying one or more regions of maximal current density on a scalp surface corresponding to the pattern of electrical activity; and
stimulating the one or more regions on the scalp surface such that the corresponding regions of the brain are stimulated.

### Claim 2 (depends on 1)

The method of claim 1 wherein recording low level brain activity and high level brain activity comprises neuroimaging the brain of the subject.

### Claim 3 (depends on 2)

The method of claim 2 wherein neuroimaging the brain comprises imaging via MEG, EEG, fMRI, PET, SPECT, ECOG, fNIRS, sMRI, DTI, or MRS.

### Claim 4 (depends on 1)

The method of claim 1 wherein determining a difference comprises subtracting areas common to both the low level brain activity and high level brain activity such that the difference image comprises areas of brain activity that change between the low performance and high performance states.

### Claim 5 (depends on 1)

The method of claim 1 wherein modeling the difference image comprises modeling via a finite element model to calculate the pattern of electrical activity.

### Claim 6 (depends on 1)

The method of claim 1 wherein stimulating the one or more regions comprises noninvasively applying a stimulation to the scalp surface.

### Claim 7 (depends on 6)

The method of claim 6 wherein the stimulation is selected from the group consisting of transcranial magnetic stimulation (TMS), repetitive TMS (rTMS), pulsed electromagnetic fields (PEMF), transcranial alternating current stimulation (TACS), transcranial random noise stimulation (TRNS), time varying electrical stimulation (TVES), and ultrasound brain stimulation (UBS).

### Claim 8 (depends on 1)

The method of claim 1 wherein stimulating the one or more regions comprises applying a single electrode polarity to the scalp surface.

### Claim 9 (depends on 8)

The method of claim 8 wherein applying a single electrode polarity comprises applying at least one anode to enhance brain activity or at least one cathode to suppress brain activity.

### Claim 10 (depends on 1)

The method of claim 1 wherein stimulating the one or more regions comprises applying the stimulation over a ramp up period, a treatment period, and a ramp down period.

### Claim 11 (depends on 10)

The method of claim 10 wherein the ramp up period ranges from 10 sees to 15 mms.

### Claim 12 (depends on 10)

The method of claim 10 wherein the ramp up period is variable.

### Claim 13 (depends on 10)

The method of claim 10 wherein the ramp down period is variable.

### Claim 14 (depends on 10)

The method of claim 10 wherein the treatment period ranges from 0.1 mins to 60 mms.

### Claim 15 (depends on 10)

The method of claim 10 wherein the treatment period comprises applying time varying stimulation having a frequency of 0 to 10,000 Hz.

### Claim 16 (depends on 10)

The method of claim 10 wherein the treatment period has a current which ranges from 0.1 rnA to 4 rnA.

### Claim 17 (depends on 10)

The method of claim 10 wherein the ramp down period ranges from 10 sees to 15 mms.

### Claim 18 (depends on 1)

The method of claim 1 wherein stimulating comprises positioning at least one electrode upon the scalp surface.

### Claim 19 (depends on 18)

The method of claim 18 wherein positioning at least one electrode comprises securing the at least one electrode to the head of the subject.

### Claim 20 (depends on 19)

The method of claim 19 further comprising introducing a conductive medium within a cavity or channel between the at least one electrode and the scalp surface.

### Claim 21 (depends on 1)

The method of claim 1 wherein stimulating the one or more regions comprises reconfiguring an electrode assembly in two or more electrode components for positioning relative to the corresponding regions of the brain.

### Claim 22 (depends on 21)

The method of claim 21 wherein positioning the two or more electrode components comprises supporting the components via a head frame configured to individually position the components relative to the regions of the brain.

### Claim 23 (depends on 1)

The method of claim 1 wherein stimulating the one or more regions comprises driving a plurality of channels where each channel provides a current source independent from one another.

### Claim 24 (depends on 23)

The method of claim 23 wherein a voltage level of each channel is controlled by an arbitrary waveform input into a controller.

### Claim 25 (depends on 23)

The method of claim 23 further comprising monitoring for an open circuit in each of the plurality of channels.

### Claim 26 (depends on 23)

The method of claim 23 further comprising monitoring an impedance over the plurality of channels to determine a mean impedance value.

### Claim 27 (depends on 26)

The method of claim 26 further comprising adjusting the current source over an electrode-to-scalp connection impedance range of 4 to 40,000 Ohms.

### Claim 28 (depends on 1)

The method of claim 1 further comprising transmitting data relating to the stimulation to a device located remotely from a controller.

### Claim 29 (depends on 1)

The method of claim 1 further comprising locking out for a predetermined period of time any further stimulation once a treatment session has been completed.

### Claim at position 30

30-64. (canceled)
